FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM 8-K CURRENT REPORT...
Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT) today reported financial results for the second quarter...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM...
SAN FRANCISCO, CA and BRIDGEWATER, NJ -- (Marketwire) -- 02/14/12 -- BioCorp Ventures LLC, a division of technology incubator US Equity Holdings...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934...
Filed Pursuant to Rule 424(b)(5) Registration No. 333-170140 PROSPECTUS SUPPLEMENT (To Prospectus dated October 26, 2010...
Free Writing Prospectus Filed Pursuant to Rule 433 Registration Number 333-170140 FINAL TERM SHEET Issuer...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...
Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE AMEX: SNT) announced today that it has entered into a securities...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.